Loading live market data…

NewAmsterdam Pharma Company N.V.

NASDAQ:NAMS

$31.98 USD

-$1.31 (-3.94%)

Volume
1.03M
Average Volume
1.3M
Market Capitalization
$3.74B
P/E Ratio
-17.67
Dividend Yield
0.00%
Price Target
$48.00
Year High
$42.21
Year Low
$20.53
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$9.76

NAMS Estimated and Actual Revenue by Quarter

NAMS Estimated and Actual EPS by Quarter

NAMS Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 6 -27.63M -10.9M -19.27M -27.63M -10.9M -19.27M
2028-09-30 3 -20.81M -8.21M -14.52M -20.82M -8.21M -14.52M
2028-06-30 5 -18.54M -7.32M -12.93M -18.54M -7.32M -12.94M
2028-03-31 3 -14.03M -5.53M -9.78M -14.03M -5.53M -9.78M
2027-12-31 7 -64.01M -25.25M -44.65M -64.01M -25.25M -44.65M
2027-09-30 4 -23.98M -9.46M -16.72M -23.98M -9.46M -16.72M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 6 -89.77M -24.99M -57.4M 49.79M 126.2M 88.03M
2028-09-30 3 -103.08M -28.69M -65.92M 37.51M 95.09M 66.32M
2028-06-30 5 -106.83M -29.74M -68.31M 33.42M 84.72M 59.09M
2028-03-31 3 -112.62M -31.35M -72.02M 25.28M 64.08M 44.69M
2027-12-31 7 2.25M 8.07M 5.16M 115.37M 292.43M 203.97M
2027-09-30 4 -64.96M -18.08M -41.54M 43.21M 109.53M 76.4M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 6 24.57M 62.29M 43.45M 7 -0.74124 -0.20632 -0.474
2028-09-30 3 18.51M 46.93M 32.74M 4 -0.85118 -0.23692 -0.5443
2028-06-30 5 16.5M 41.81M 29.16M 6 -0.88214 -0.24554 -0.5641
2028-03-31 3 12.48M 31.63M 22.06M 4 -0.92999 -0.25885 -0.5947
2027-12-31 7 56.94M 144.33M 100.67M 6 0.01854245 0.06661785 0.0426
2027-09-30 4 21.33M 54.06M 37.71M 3 -0.53638 -0.1493 -0.343